We use cookies to provide you with a better service. Carry on browsing if you’re happy with this or read more about our cookie policy and privacy policy.
This revolutionary treatment option results in a significantly improved quality of life in 93% of patients who take it and a reduction in the need for
Results Patients offered ESC or palliative care review at diagnosis increased (43%-93%) The service was accepted by 85% of patients Symptom burden was
The condition has an autosomal recessive mode of inheritance and depending on the population, 80-93% of individuals with type I HH are homozygous for the
patients (n=2) had a pre-existing DNAR and CPR was not deemed appropriate for 23% patients (n=30) 62% patients (n=58) required IMV out of 72% patients (n=93
Compliance improved to 92% with ‘sign in’ and to 93% with ‘time out’. Engagement by the entire theatre time was achieved 100% of the time.
Aim To increase the number of initial investigations from a baseline of 40% to 93% in 6 months.
Verbal feedback from patients, relatives, and staff are all positive, Baseline audit gathered across site 173 patients with 93 days of delirium post audit
With over 93% of patients telling us they find mobile units more convenient, the impact of providing treatment in local communities is clear.
